207 related articles for article (PubMed ID: 9597800)
41. [Stem cells in hematology and oncology].
Goldschmidt H; Egerer G; Fruehauf S; Ho AD
Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
[TBL] [Abstract][Full Text] [Related]
42. Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome.
Minnema MC; van de Donk NW; Zweegman S; Hegenbart U; Schonland S; Raymakers R; Zijlmans JM; Kersten MJ; Bos GM; Lokhorst HM
Bone Marrow Transplant; 2008 May; 41(9):779-84. PubMed ID: 18195681
[TBL] [Abstract][Full Text] [Related]
43. High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients.
Martino M; Console G; Irrera G; Praticò G; Stelitano C; Callea V; Morabito F; Quartarone E; Musolino C; Piro E; Brugiatelli M; Iacopino P
Am J Hematol; 2006 Dec; 81(12):973-8. PubMed ID: 16888786
[TBL] [Abstract][Full Text] [Related]
44. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
[TBL] [Abstract][Full Text] [Related]
45. Molecular pathogenesis of multiple myeloma.
Tonon G
Hematol Oncol Clin North Am; 2007 Dec; 21(6):985-1006, vii. PubMed ID: 17996585
[TBL] [Abstract][Full Text] [Related]
46. Biologic and clinical advances in multiple myeloma.
Varterasian ML
Oncology (Williston Park); 1995 May; 9(5):417-24; discussion 429-30. PubMed ID: 7547203
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors in multiple myeloma: practicability for clinical practice and future perspectives.
Haferlach T; Löffler H
Leukemia; 1997 Dec; 11 Suppl 5():S5-9. PubMed ID: 9436931
[TBL] [Abstract][Full Text] [Related]
48. Biology and treatment of myeloma.
Greipp PR; Witzig T
Curr Opin Oncol; 1996 Jan; 8(1):20-7. PubMed ID: 8868095
[TBL] [Abstract][Full Text] [Related]
49. Advances in the biology and therapeutic management of multiple myeloma.
Kaufmann H; Urbauer E; Ackermann J; Huber H; Drach J
Ann Hematol; 2001 Aug; 80(8):445-51. PubMed ID: 11563588
[TBL] [Abstract][Full Text] [Related]
50. New approaches to management of multiple myeloma.
Hájek R; Vásová I; Adam Z; Mayer J
Acta Med Austriaca; 1996; 23(3):91-8. PubMed ID: 8798282
[TBL] [Abstract][Full Text] [Related]
51. [Multiple myeloma: etiology, epidemiology, tumor biology and pathophysiology].
Kanoh T
Nihon Rinsho; 1995 Mar; 53(3):543-51. PubMed ID: 7699883
[TBL] [Abstract][Full Text] [Related]
52. Biology and treatment of multiple myeloma.
Mandelli F; Avvisati G; Tribalto M
Curr Opin Oncol; 1992 Feb; 4(1):73-86. PubMed ID: 1591296
[TBL] [Abstract][Full Text] [Related]
53. Myeloma biology and therapy. Present status and future developments.
Nishimoto N; Shima Y; Yoshizaki K; Kishimoto T
Hematol Oncol Clin North Am; 1997 Feb; 11(1):159-72. PubMed ID: 9081210
[TBL] [Abstract][Full Text] [Related]
54. [Advances in biology and pathogenesis of multiple myeloma].
Kosaka M; Abe M; Takishita M; Ozaki S; Goto T
Nihon Rinsho; 1995 Mar; 53(3):627-35. PubMed ID: 7699896
[TBL] [Abstract][Full Text] [Related]
55. Biology and treatment of myeloma.
Brioli A; Melchor L; Walker BA; Davies FE; Morgan GJ
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S65-70. PubMed ID: 25486959
[TBL] [Abstract][Full Text] [Related]
56. Synopsis of a roundtable on validating novel therapeutics for multiple myeloma.
Dalton W; Anderson KC
Clin Cancer Res; 2006 Nov; 12(22):6603-10. PubMed ID: 17121878
[TBL] [Abstract][Full Text] [Related]
57. Molecular aspects of multiple myeloma.
Kastrinakis NG; Gorgoulis VG; Foukas PG; Dimopoulos MA; Kittas C
Ann Oncol; 2000 Oct; 11(10):1217-28. PubMed ID: 11106109
[TBL] [Abstract][Full Text] [Related]
58. Multiple myeloma: an overview.
Devenney B; Erickson C
Clin J Oncol Nurs; 2004 Aug; 8(4):401-5. PubMed ID: 15354927
[TBL] [Abstract][Full Text] [Related]
59. Plasma cell myeloma--new biological insights and advances in therapy.
Barlogie B; Epstein J; Selvanayagam P; Alexanian R
Blood; 1989 Mar; 73(4):865-79. PubMed ID: 2465790
[TBL] [Abstract][Full Text] [Related]
60. [Multiple myeloma--pathophysiology and treatment].
Gahrton G; Björkholm M; Mellstedt H; Ost A
Lakartidningen; 1988 May; 85(19):1707-10, 1713. PubMed ID: 2453765
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
